briplatin
Small moleculeexperimental
Cisplatin is a chemical compound with formula cis-[Pt(NH3)2Cl2]. It is a coordination complex of platinum that is used as a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. It is given by injection into a vein. — Wikipedia
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2003 (NCT00209690)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCisplatin ↗
Also known as
- briplatin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00209716 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2003 | Hokkaido University |
| NCT00209690 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2003 | Hokkaido University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hokkaido University | Academic/Hospital | 2 | 2 | 1 | 2003 |
1 organizations
Page 1 / 1